Table 2 Analysis results for the top genes including new and already established driver gene candidates. The table is split according to top 10 oncogene candidates (A) and top 10 tumor suppressor gene candidates (B)

AKT1

5.5

136

<1E-16

1.8

1.60E-15

0.64

ATG2B

5.1

20

6.70E-09

1.4

6.90E-14

0.66

COL6A2

5.3

151

3.60E-13

1.5

1.50E-09

0.72

MTUS2

5.8

97

6.90E-06

1.3

1.10E-16

0.63

OSBPL10

5.2

46

2.40E-08

1.4

1.80E-12

0.68

POTEF

5.7

16

1.60E-11

1.4

5.60E-16

0.64

SCLT1

5.5

27

3.90E-08

1.4

5.10E-13

0.67

TNC

6

15

1.10E-07

1.3

<1E-16

0.63

TRANK1

5.3

10

<1E-16

1.7

1.90E-05

0.79

TRAPPC10

6.1

3

<1E-16

1.7

2.60E-11

0.69

ARFGEF1

6.4

63

<1E-16

0.52

<1E-16

1.7

BRCA2

6

74

<1E-16

0.52

2.20E-16

1.6

GGA3

5.5

359

<1E-16

0.49

1.40E-14

1.5

MPP6

5.5

48

<1E-16

0.53

<1E-16

1.8

PHEX

6.6

20

<1E-16

0.47

2.60E-15

1.5

PXDNL

6.1

255

<1E-16

0.51

<1E-16

1.6

RGS22

6

350

<1E-16

0.5

<1E-16

1.7

TP53

28.3

1566

<1E-16

0.48

5.60E-16

1.6

UBR5

9.9

8

<1E-16

0.53

<1E-16

1.7

UNC5D

6.6

51

<1E-16

0.54

<1E-16

1.8